← back to search

Wayne M. Koch

Johns Hopkins University · US
Area of research
Otorhinolaryngology · Surgery
Research interest
Research interests include Head and Neck Cancer Studies, Head and Neck Surgical Oncology, Epigenetics and DNA Methylation, and Cancer-related molecular mechanisms research.
h-index
87
citations
31,180
works
467
NIH funding
primary concept
email

Recent publications

Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus–Initiated Oropharynx Cancer
Journal of Clinical Oncology 2025cited by 10position: middledoi
Long-term follow up of E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.
Journal of Clinical Oncology 2024cited by 8position: middledoi
Review of: "Decolonisation of Health in East Africa: Opinion Piece"
2023cited by 0position: contributordoi
Outcomes by tobacco history in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.
Journal of Clinical Oncology 2022cited by 12position: middledoi
Updated report of a phase II randomized trial of transoral surgical resection followed by low-dose or standard postoperative therapy in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN cancer research group (E3311).
Journal of Clinical Oncology 2021cited by 26position: middledoi
Global Burden of Head and Neck Cancer: Economic Consequences, Health, and the Role of Surgery
Otolaryngology 2020cited by 131position: middledoi
Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).
Journal of Clinical Oncology 2020cited by 100position: middledoi
HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers
Oncogene 2020cited by 98position: middledoi
A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311
Oral Oncology 2020cited by 44position: middledoi
GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma
Science Signaling 2020cited by 40position: middledoi
African Head and Neck Society Clinical Practice guidelines for thyroid nodules and cancer in developing countries and limited resource settings
Head & Neck 2020cited by 29position: middledoi
Distinct biomarker and behavioral profiles of human papillomavirus-related oropharynx cancer patients by age
Oral Oncology 2019cited by 24position: middledoi
Oral Human Papillomavirus Infection and Head and Neck Squamous Cell Carcinoma in Rural Northwest Cameroon
OTO Open 2019cited by 18position: lastdoi
Increasing prevalence of human papillomavirus–positive oropharyngeal cancers among older adults
Cancer 2018cited by 162position: middledoi
Prognostic factors for human papillomavirus–positive and negative oropharyngeal carcinomas
The Laryngoscope 2018cited by 31position: middledoi
Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial
Annals of Oncology 2018cited by 8position: middledoi
The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer
Cancer 2017cited by 235position: middledoi
Integrated Analysis of Whole-Genome ChIP-Seq and RNA-Seq Data of Primary Head and Neck Tumor Samples Associates HPV Integration Sites with Open Chromatin Marks
Cancer Research 2017cited by 73position: middledoi
16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment
Oncotarget 2016cited by 314position: middledoi
Assessment of the Predictive Value of the Modified Frailty Index for Clavien-Dindo Grade IV Critical Care Complications in Major Head and Neck Cancer Operations
JAMA Otolaryngology–Head & Neck Surgery 2016cited by 97position: middledoi
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
Science Translational Medicine 2015cited by 499position: middledoi
Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma
Clinical Cancer Research 2015cited by 184position: middledoi
Surgical salvage improves overall survival for patients with HPV‐positive and HPV‐negative recurrent locoregional and distant metastatic oropharyngeal cancer
Cancer 2015cited by 148position: middledoi
Cetuximab activity in dysplastic lesions of the upper aerodigestive tract
Oral Oncology 2015cited by 14position: middledoi
Saliva and Plasma Quantitative Polymerase Chain Reaction–Based Detection and Surveillance of Human Papillomavirus–Related Head and Neck Cancer
JAMA Otolaryngology–Head & Neck Surgery 2014cited by 240position: middledoi
Head and Neck PET/CT: Therapy Response Interpretation Criteria (Hopkins Criteria)—Interreader Reliability, Accuracy, and Survival Outcomes
Journal of Nuclear Medicine 2014cited by 188position: middledoi
Key tumor suppressor genes inactivated by “greater promoter” methylation and somatic mutations in head and neck cancer
Epigenetics 2014cited by 146position: middledoi
Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke
Head & Neck 2014cited by 78position: middledoi
Human Papillomavirus–related Carcinoma With Adenoid Cystic–like Features
The American Journal of Surgical Pathology 2013cited by 171position: middledoi
Detection of Transcriptionally Active High-risk HPV in Patients With Head and Neck Squamous Cell Carcinoma as Visualized by a Novel E6/E7 mRNA In Situ Hybridization Method
The American Journal of Surgical Pathology 2012cited by 342position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jeremy D. Richmon · Massachusetts Eye and Ear Infirmary6 papers (2015–2025)Carole Fakhry · Johns Hopkins University6 papers (2015–2019)Patrick K. Ha · UCSF Helen Diller Family Comprehensive Cancer Center6 papers (2015–2019)Robert L. Ferris · UPMC Hillman Cancer Center6 papers (2015–2025)David W. Eisele · Johns Hopkins University6 papers (2015–2019)William H. Westra · Mount Sinai Hospital6 papers (2012–2019)Ranee Mehra · The Ohio State University5 papers (2020–2025)R. Bryan Bell · Oregon Health & Science University5 papers (2020–2025)Bert W. O’Malley · Children's Cancer Center5 papers (2020–2025) · 5 papers (2020–2025)Gregory S. Weinstein · University of Pennsylvania5 papers (2020–2025)Enver Özer · The Ohio State University5 papers (2020–2025)Gypsyamber DʼSouza · Instituto Lauro de Souza Lima5 papers (2015–2019)Barbara Burtness · Yale University5 papers (2020–2025) · 5 papers (2020–2025)Harry Quon · Johns Hopkins Medicine5 papers (2020–2025)Joaquín J. García · Mayo Clinic4 papers (2020–2024)Eleni M. Rettig · Dana-Farber Cancer Institute4 papers (2017–2019)William R. Ryan · Sutter Health4 papers (2017–2019)Nishant Agrawal · Institute of Chartered Financial Analysts of India4 papers (2014–2016)